Array Biopharma (ARRY) Gives Up Earlier Gains; Falls 2%
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Yesterday's momentum stock du jour Array Biopharma (NASDAQ: ARRY) has broken lower after opening sharply higher. Shares are down 2% after gaining 81% on Monday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SunEdison (SUNEQ) Shares Ramp to Session Highs
- Equity and Commodity Markets
- UPDATE: Aduro Biotech (ADRO), Inovio Pharma (INO), and Merchants Bancshares (MBVT) trading halted with news pending
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!